These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 31134857
1. Medication Adherence to Antihypertensive Triple-Combination Therapy Among Patients Enrolled in a Medicare Advantage Plan. Wang X, Chen H, Essien E, Wu J, Serna O, Paranjpe R, Abughosh S. J Manag Care Spec Pharm; 2019 Jun; 25(6):678-686. PubMed ID: 31134857 [Abstract] [Full Text] [Related]
2. Risk of Cardiovascular Outcomes and Antihypertensive Triple Combination Therapy Among Elderly Patients with Hypertension Enrolled in a Medicare Advantage Plan (MAP). Wang X, Chen H, Essien EJ, Wu J, Serna O, Paranjpe R, Abughosh S. Am J Cardiovasc Drugs; 2020 Dec; 20(6):591-602. PubMed ID: 32043245 [Abstract] [Full Text] [Related]
3. Cost-effectiveness analysis of antihypertensive triple combination therapy among patients enrolled in a Medicare advantage plan. Wang X, Chen H, E E, Wu J, Serna O, Paranjpe R, Abughosh S. Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):829-836. PubMed ID: 32703040 [Abstract] [Full Text] [Related]
4. Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence. Abughosh SM, Vadhariya A, Johnson ML, Essien EJ, Esse TW, Serna O, Gallardo E, Boklage SH, Choi J, Holstad MM, Fleming ML. J Manag Care Spec Pharm; 2019 Oct; 25(10):1053-1062. PubMed ID: 31556824 [Abstract] [Full Text] [Related]
5. Evaluating Success Factors of a Medication Adherence Tracker Pilot Program in Improving Part D Medication Adherence Metrics in a Medicare Advantage Plan: Importance of Provider Engagement. Hong M, Esse T, Vadhariya A, Gallardo E, Fosshat MA, Mamvou J, Bruce L, Serna O, Abughosh S. J Manag Care Spec Pharm; 2020 May; 26(5):662-667. PubMed ID: 32347173 [Abstract] [Full Text] [Related]
6. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial. Sung J, Ahn KT, Cho BR, Lee SY, Kim BJ, Kim DK, Park JI, Lee WS. Clin Transl Sci; 2021 May; 14(3):1185-1192. PubMed ID: 33503302 [Abstract] [Full Text] [Related]
7. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan. Abughosh SM, Wang X, Serna O, Henges C, Masilamani S, Essien EJ, Chung N, Fleming M. J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053 [Abstract] [Full Text] [Related]
8. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy. Xie L, Frech-Tamas F, Marrett E, Baser O. Curr Med Res Opin; 2014 Dec; 30(12):2415-22. PubMed ID: 25222764 [Abstract] [Full Text] [Related]
9. Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients. Panjabi S, Lacey M, Bancroft T, Cao F. J Am Soc Hypertens; 2013 Dec; 7(1):46-60. PubMed ID: 23321404 [Abstract] [Full Text] [Related]
10. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool. Mhatre SK, Serna O, Sansgiry S, Fleming ML, Essien EJ, Sansgiry SS. J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546 [Abstract] [Full Text] [Related]
11. Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial. Webster R, Salam A, de Silva HA, Selak V, Stepien S, Rajapakse S, Amarasekara S, Amarasena N, Billot L, de Silva AP, Fernando M, Guggilla R, Jan S, Jayawardena J, Maulik PK, Mendis S, Mendis S, Munasinghe J, Naik N, Prabhakaran D, Ranasinghe G, Thom S, Tisserra N, Senaratne V, Wijekoon S, Wijeyasingam S, Rodgers A, Patel A, TRIUMPH Study Group. JAMA; 2018 Aug 14; 320(6):566-579. PubMed ID: 30120478 [Abstract] [Full Text] [Related]
14. Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study. Lauffenburger JC, Landon JE, Fischer MA. J Gen Intern Med; 2017 Jun 14; 32(6):619-625. PubMed ID: 28050754 [Abstract] [Full Text] [Related]
15. Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel. Iyengar RN, LeFrancois AL, Henderson RR, Rabbitt RM. J Manag Care Spec Pharm; 2016 May 14; 22(5):550-60. PubMed ID: 27123916 [Abstract] [Full Text] [Related]
16. National Rates of Nonadherence to Antihypertensive Medications Among Insured Adults With Hypertension, 2015. Chang TE, Ritchey MD, Park S, Chang A, Odom EC, Durthaler J, Jackson SL, Loustalot F. Hypertension; 2019 Dec 14; 74(6):1324-1332. PubMed ID: 31679429 [Abstract] [Full Text] [Related]
17. The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis. Du LP, Cheng ZW, Zhang YX, Li Y, Mei D. J Clin Hypertens (Greenwich); 2018 May 14; 20(5):902-907. PubMed ID: 29700923 [Abstract] [Full Text] [Related]
18. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior. Leslie RS, Gilmer T, Natarajan L, Hovell M. J Manag Care Spec Pharm; 2016 May 14; 22(5):526-38. PubMed ID: 27123914 [Abstract] [Full Text] [Related]
19. Alignment of diagnosis and pharmacy claims data coding of medication adherence among patients with diabetes or hypertension. Gatwood J, Hohmeier KC, Shuvo S, Mikaiel D, Kovesdy CP. J Manag Care Spec Pharm; 2021 Apr 14; 27(4):497-506. PubMed ID: 33769854 [Abstract] [Full Text] [Related]
20. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications. Majd Z, Mohan A, Paranjpe R, Abughosh SM. J Manag Care Spec Pharm; 2021 Feb 14; 27(2):186-197. PubMed ID: 33506725 [Abstract] [Full Text] [Related] Page: [Next] [New Search]